Demant A/S (CO:DEMANT) — Market Cap & Net Worth
Market Cap & Net Worth: Demant A/S (DEMANT)
Demant A/S (CO:DEMANT) has a market capitalization of $9.76 Billion (Dkr62.38 Billion) as of September 17, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #2273 globally and #13 in its home market, demonstrating a 2.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Demant A/S's stock price Dkr295.80 by its total outstanding shares 210898609 (210.90 Million). Also see DEMANT total asset value for a full breakdown of the balance sheet.
Demant A/S Market Cap History: 2015 to 2026
Demant A/S's market capitalization history from 2015 to 2026. Data shows growth from $4.34 Billion to $9.76 Billion (8.45% CAGR). Also see DEMANT cash flow conversion for how efficiently the company converts equity into cash flow.
Demant A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Demant A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Demant A/S for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.31x
Demant A/S's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.60x
Demant A/S's market cap is 4.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $4.05 Billion | $12.00 Billion | $1.46 Billion | 0.34x | 2.78x |
| 2017 | $5.72 Billion | $13.19 Billion | $1.75 Billion | 0.43x | 3.26x |
| 2018 | $6.10 Billion | $13.94 Billion | $1.82 Billion | 0.44x | 3.35x |
| 2019 | $6.92 Billion | $14.95 Billion | $1.46 Billion | 0.46x | 4.74x |
| 2020 | $7.94 Billion | $14.47 Billion | $1.12 Billion | 0.55x | 7.08x |
| 2021 | $11.06 Billion | $18.39 Billion | $2.51 Billion | 0.60x | 4.40x |
| 2022 | $6.35 Billion | $19.70 Billion | $2.08 Billion | 0.32x | 3.05x |
| 2023 | $9.77 Billion | $22.44 Billion | $1.79 Billion | 0.44x | 5.44x |
| 2024 | $8.72 Billion | $22.42 Billion | $2.39 Billion | 0.39x | 3.65x |
| 2025 | $7.10 Billion | $23.08 Billion | $1.54 Billion | 0.31x | 4.60x |
Competitor Companies of DEMANT by Market Capitalization
Companies near Demant A/S in the global market cap rankings as of September 17, 2026. Review DEMANT intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Demant A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Demant A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, Demant A/S's market cap moved from $4.34 Billion to $ 9.76 Billion, with a yearly change of 8.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr9.76 Billion | +37.45% |
| 2025 | Dkr7.10 Billion | -18.55% |
| 2024 | Dkr8.72 Billion | -10.74% |
| 2023 | Dkr9.77 Billion | +53.73% |
| 2022 | Dkr6.35 Billion | -42.54% |
| 2021 | Dkr11.06 Billion | +39.28% |
| 2020 | Dkr7.94 Billion | +14.68% |
| 2019 | Dkr6.92 Billion | +13.47% |
| 2018 | Dkr6.10 Billion | +6.57% |
| 2017 | Dkr5.72 Billion | +41.29% |
| 2016 | Dkr4.05 Billion | -6.54% |
| 2015 | Dkr4.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Demant A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.76 Billion USD |
| MoneyControl | $9.76 Billion USD |
| MarketWatch | $9.76 Billion USD |
| marketcap.company | $9.76 Billion USD |
| Reuters | $9.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more